Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
SGS Acquires Keystone Bioanalytical, Strengthening End-to-End Drug Development Lifecycle Testing Capabilities for North American Pharma and Biotech Industries
BLOOMFIELD, N.J., May 4, 2026 /CNW/ - SGS, the world's leading testing, inspection and certification company, is pleased to announce that it has acquired Keystone Bioanalytical, a specialized provider of bioanalytical testing services based in…
Dr. Falk Pharma and Renexxion announce positive results on naronapride in gastroparesis from the global phase 2b MOVE-IT trial
MOVE-IT met the primary endpoint with statistically significant improvement in gastroparesis symptoms in 20 mg and 40 mg TID doses vs placebo Improvements observed across key symptoms, including nausea, early satiety, post-prandial fullness and…
Bubble effect': Weight loss drug fueled growth is putting the pharma sector at risk, report finds
For the first time in 16 years, oncology is no longer the largest contributor to late-stage pipeline value, Deloitte has found. Pharma R&D returns for the world's top 20 pharma companies have improved for a third year straight to 7%, driven by…
The drug-pricing problem no one wants to talk about
For the past year countries have been at odds over how to lower drug prices. As United States President Donald Trump sees it, US prices should drop and other countries' prices should rise to make up for lost pharma revenue. For Swiss authorities…
Orion Corporation: Managers' transactions - Henrik Stenqvist
Orion Corporation: Managers' transactions – Henrik Stenqvist Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion…
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
Jeremy B. Fitch, MBA, appointed as Chief Business Officer Michael A. Alrutz, J.D., Ph.D., appointed as General Counsel Guy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United Kingdom and NEW YORK, May 04, 2026 – Artios…
India needs a future-ready workforce to sustain its global leadership in pharmaceuticals: experts
Experts at a webinar underscored the need for India to strengthen its innovation ecosystem, streamline regulatory frameworks, and build a future-ready workforce to sustain its global leadership in pharmaceuticals. The webinar, “Pharma 2030:…
Small Language Models trained for your industry can deliver more for your business
Asked why he robbed banks, the American bank robber Willie Sutton is supposed to have answered, “because that's where the money is.” It's a limited point of view, but logical. I'm seeing a trend among enterprise executives today that…
Ardena Strengthens Executive Team to Drive its Next Phase of Growth
Ghent, Belgium, 4 May 2026 – Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and other complex therapies, announces the appointments of Ben Ash as Chief Financial Officer and Henny Zijlstra as…
Eli Lilly Just Announced Fantastic News for Shareholders
Eli Lilly 's (LLY +3.30%) broad range of drugs has helped build its success over time, but in recent years, one particular portfolio has supercharged growth. I'm talking about the company's weight loss drugs. The key product is tirzepatide, sold…
Is Doximity, Inc. (DOCS) A Good Stock To Buy Now?
Is DOCS a good stock to buy? We came across a bullish thesis on Doximity, Inc. on The Cash Flow Compounder's Substack. In this article, we will summarize the bulls' thesis on DOCS. Doximity, Inc.'s share was trading at $24.15 as of April 21st.
HP Enterprise: AI Drives The Dominant Growth Theme, As Buy Rating Reaffirmed (NYSE:HPE)
Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…
Development of RRR northern section to be taken up in two separate packages
The northern part of the ambitious regional ring road (RRR) project, proposed as access controlled greenfield expressway, from Girmapur to Tangadpalle village in northern Telangana, will be taken up in two separate packages. The Public Private…
Is Precigen, Inc. (PGEN) A Good Stock To Buy Now?
Is PGEN a good stock to buy? We came across a bullish thesis on Precigen, Inc. on Valueinvestorsclub.com by coalone. In this article, we will summarize the bulls' thesis on PGEN. Precigen, Inc.'s share was trading at $4.0200 as of April 28. PGEN's…
'Free markets' and shackled access to medicines
Billions of people around the world, including in India, lack the ability to access affordable medicines. Nearly one in three Americans struggles to afford prescription drugs. Drug companies delay launching new products in Europe because of the…
Receive a Daily briefing on Pharma Industry News
Get Started